PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Therapies & Rehabilitation, University College London Hospitals NHS Foundation Trust, London, UK o.mccourt@nhs.net.\', \'Research Department of Haematology, Cancer Institute, University College London, London, UK.\', \'Research Department of Behavoural Science and Health, University College London, London, UK.\', \'Queen Square Centre for Neuromuscular Diseases, National Hosital for Neurology and Neurosurger, London, UK.\', \'Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/bmjopen-2021-059516
?:doi
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 35396313
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Adaptation of the PERCEPT myeloma prehabilitation trial to virtual delivery: changes in response to the COVID-19 pandemic.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all